A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1986
10/07/1986	US4615699 Impervious backing, nitroglycerin release control membranes, and nitroglycerin-ethanol reseroir
10/07/1986	CA1212497A1 Crosslinked .beta.-alanine, and its various uses
10/07/1986	CA1212381A1 Crystal modifications of ( )-catechin and processes for their production
10/07/1986	CA1212380A1 Process for the preparation of new thieno(2,3-b) pyrrole derivatives
10/07/1986	CA1212379A1 Amino derivatives of benzylidene-pyrrolo[2,1- b]quinazolines and benzylidene-pyrido[2,1- b]quinazolines
10/07/1986	CA1212378A1 .beta.-LACTAMASE INHIBITING 2-.beta.-SUBSTITUTED-2-.alpha.- METHYL-(5R) PENAM-3-.alpha.-CARBOXYLIC ACID 1,1- DIOXIDES AND INTERMEDIATES THEREFOR
10/07/1986	CA1212330A1 Pharmaceutical compositions having antineoplastic activity
10/07/1986	CA1212329A1 Chlorthalidone dispersions
10/07/1986	CA1212328A1 Antimycotic agents with a high release of active compound, in the form of a solution and spray
10/07/1986	CA1212327A1 Antimycotic agent with a high release of active compound, in the form of a cream
10/07/1986	CA1212326A1 Liquid formulations of dihydropyridines, a process for their preparation, and their use in combating diseases
10/07/1986	CA1212325A1 Antibacterial pharmaceutical composition and/or fodder premix and a process for the preparation thereof
10/07/1986	CA1212324A1 Fat emulsion containing prostaglandin
10/07/1986	CA1212323A1 Method for improving gastrointestinal motility
10/07/1986	CA1212322A1 Pharmaceutical formulations
10/01/1986	EP0196271A2 Estradiol and/or estriol glycolic-acid esters
10/01/1986	EP0196270A2 Aqueous crystalline suspensions of glycolic-acid esters of steroids
10/01/1986	EP0196268A2 Estriol esters
10/01/1986	EP0196222A2 Hypoglycemic agent
10/01/1986	EP0196189A2 Novel enzyme inhibiting substance
10/01/1986	EP0196185A2 Antiviral nucleosides
10/01/1986	EP0196184A2 Aryl derivatives
10/01/1986	EP0196132A2 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
10/01/1986	EP0196121A1 Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
10/01/1986	EP0196096A2 Imide derivatives, their production and use
10/01/1986	EP0196085A2 Composition containing ubidecarenone with promoted absorption
10/01/1986	EP0196079A1 Therapeutic use of tin mesoporphyrin
10/01/1986	EP0196039A2 Use of 1-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)-ethan-1-ol for the preparation of medicaments for viral diseases.
10/01/1986	EP0196024A1 Substituted 1,8-naphthyridinones, processes for their preparation and pharmaceutical compositions containing them
10/01/1986	EP0196016A2 3-nitropyridine-derivatives, process for their preparation and pharmaceutical composition containing them
10/01/1986	EP0196005A1 Pyridazinones, their preparation and pharmaceutical compositions containing them
10/01/1986	EP0195947A2 Beta-lactam antibiotics, process for their preparation and their use as and in medicaments
10/01/1986	EP0195939A2 Imidazodiazepine derivatives
10/01/1986	EP0195906A2 Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties
10/01/1986	EP0195888A2 Use of 2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[5,4-d]azepin in the reduction of prolactin serum levels
10/01/1986	EP0195841A1 Quinolinecarboxylic acid derivatives and process for their preparation
10/01/1986	EP0028257B1 L-threonine for regulating glycine levels in the brain and spinal cord
10/01/1986	CN86102020A Process for the prepn. of rhizoxin derivatives and pharmaceutical use
10/01/1986	CN86101906A Process for the preparation of novel 1,2-benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
10/01/1986	CN86100820A Process for the preparation of new cephalosporine and their use in medicaments
10/01/1986	CN86100624A Process for the preparation bile-substituting pharmaceotical composition for the promotion of fat digestion
10/01/1986	CN85109229A Improvements in or relating to dobutamine salts
10/01/1986	CN85107365A Thiamine salt granules and their production
10/01/1986	CN85106532A Preparation of cephem derivative
10/01/1986	CN85104470A Process for the preparation of arythydroxamates
10/01/1986	CN85102398A Catalyst for synthesizing pure l-borneol, its preparation and application
10/01/1986	CN85100796A Process for preparing quinolone derivatives
09/1986
09/30/1986	US4614833 Analgesics, antiinflammatory agents, antipyretics, sedatives
09/30/1986	US4614824 Novel apovincaminic acid derivatives
09/30/1986	US4614819 Reacting a thiol ester compound with 7-aminocephalosporin in presence of boron trifluoride
09/30/1986	US4614805 Bicyclic amino acids as intermediates in the preparation of tricyclic amino acids and processes for their preparation
09/30/1986	US4614802 6-substituted amino-4H-pyrano(3,2-G)quinoline-2,8-dicarboxylic acid intermediates
09/30/1986	US4614797 Cephalosporin hydroxamic acids
09/30/1986	US4614748 Topical use composition for the treatment of seborrhea affections of the human scalp
09/30/1986	US4614747 Derivatives of alpha-alkyl polyolefinic carboxylic acid useful in the treatment of psoriasis
09/30/1986	US4614746 5-fluorobenzonitrile derivatives for increasing the lean meat to fat ratio and/or enhancing the growth rate of warm-blooded animals
09/30/1986	US4614745 Anti-allergic 3-(carboxycarbonyl)amino benzothiopyran-4-one derivatives, compositions, and method of use therefor
09/30/1986	US4614744 Use of fenpyramin as platelet-antiaggregating, vasodilating, antithrombotic and antianginous medicine
09/30/1986	US4614743 Methods of treating pain and inflammation with 4,7-dimethyl-2-(4-pyridinyl)-1,2,4,-triazolo[1,5-a]pyrimidin-5(4H)-one or the pharmaceutically acceptable salts or solvates thereof
09/30/1986	US4614741 Injectable suspensions
09/30/1986	US4614740 Nervous system disorders
09/30/1986	US4614739 Oxindole derivatives, pharmaceutical compositions and use
09/30/1986	US4614738 2-(N-heterocycloaliphaticthio)penems
09/30/1986	US4614736 Novel anti-inflammatory treatment
09/30/1986	US4614733 Polysaccharides pharmaceutical compositions and the use thereof
09/30/1986	US4614650 Cytotoxic composition including at least an immunotoxine and an amine
09/30/1986	US4614618 1,4-bis(substituted-amino)-5,8-dihydroxy anthraquinones and leuco bases thereof
09/30/1986	US4614617 Intermediates for 8-chlorodibenz[(b,f)][1,4]oxazepine-10(11H)-carboxylic acid, 2-(sulfinyl- and sulfonyl-containing acyl)hydrazides
09/30/1986	CA1212117A1 Propynylaminothiazole derivatives
09/30/1986	CA1212114A1 Process for the preparation of ellipticin derivatives, new compositions thus obtained and anti-tumoral activity thereof
09/30/1986	CA1212111A1 Process for preparing new bicyclo ¬4.2.0\| octatri-1,3,5-ene derivatives
09/30/1986	CA1212103A1 Indolylglycyl cephalosporin derivatives
09/30/1986	CA1212102A1 15,16-methylene-17-pregna-4,6-diene-21-carboxylic acid salts, pharmaceutical preparations containing them and a process for their production
09/25/1986	WO1986005491A1 Synthesis of vinblastine and vincristine type compounds
09/25/1986	WO1986005490A1 2-arylbenzothiazine derivatives
09/25/1986	WO1986005488A1 9-halogenprostaglandines, process for their manufacture
09/25/1986	WO1986005485A1 Amides of non-steroidal anti-inflammatory carboxylic acids
09/25/1986	WO1986005395A1 Composition for treating skin disease
09/25/1986	WO1986005394A1 Compositions for treating acne vulgaris and methods of making and using same
09/25/1986	WO1986005391A1 Antiseptic fluids
09/24/1986	EP0195749A2 Use of benzydamine in the treatment of the trichomonas vaginalis and gardnerella vaginalis infections
09/24/1986	EP0195730A2 Sweeteners derived from glycine and beta-alanine, process for sweetening various products and compositions containing such sweeteners
09/24/1986	EP0195668A2 Carbacyclin derivatives
09/24/1986	EP0195667A2 Cardiotonic quinazoline derivatives
09/24/1986	EP0195582A1 5-Aminosalicylic acid derivatives of non-steroidal antiinflammatory acids
09/24/1986	EP0195570A2 Pharmaceutical compositions
09/24/1986	EP0195557A2 Triazole antifungal agents
09/24/1986	EP0195496A2 Use of xanthines in the treatment of proliferative skin disease
09/24/1986	EP0195433A1 Amide derivatives processes for preparing them and use thereof
09/24/1986	EP0195397A1 m-Cyanophenethanolamines as animal growth promoters and antilipogenic agents
09/24/1986	EP0195396A1 5-Fluorobenzonitrile derivatives and pharmacologically acceptable acid addition salts thereof for increasing the lean meat to fat ratio, and/or enhancing the growth rate of warm-blooded animals
09/24/1986	EP0195379A2 Allenic prostacyclins
09/24/1986	EP0195374A2 N-substituted 3,4-dihydropyrimidine derivatives, process for the production thereof and composition containing same for treating disorders of cardiovascular system
09/24/1986	EP0195212A2 Novel peptidase inhibitors
09/24/1986	EP0195201A2 Process for the preparation of N-acyl-2,3-dehydro carboxylic esters
09/24/1986	EP0195169A2 Therapeutic use of the monosialoganglioside GM1 in severe cerebral ischemic strokes pathologies
09/24/1986	EP0195147A1 Trihalo(amine)gold(III) complexes
09/24/1986	EP0195114A2 Stabilized injection compositions and their preparations
09/24/1986	CN86100913A Method of producing high molecular weight sodium hyaluronate by fermentation of streptococcus
09/24/1986	CN86100868A Vectors and methods for expression of human protein c activity

1 ... 7595 7596 7597 7598 7599 7600 7601 7602 7603 7604 7605 7606 7607 7608 7609 7610 7611 7612 7613 7614 7615 ... 7860